Crossmark

The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever

Crossref DOI link: https://doi.org/10.1007/s00296-023-05351-0

Published Online: 2023-06-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cebeci, Sinem Oral https://orcid.org/0000-0003-2219-7345
Yildiz, Mehmet https://orcid.org/0000-0002-7834-4909
Gunalp, Aybuke https://orcid.org/0000-0003-0137-0460
Cebi, Memnune Nur https://orcid.org/0000-0002-1327-0638
Kilinc, Berivan https://orcid.org/0009-0000-0581-2866
Pinar, Eymen https://orcid.org/0000-0002-5466-0915
Konte, Elif Kilic https://orcid.org/0000-0002-8174-5308
Aslan, Esma https://orcid.org/0000-0002-7554-3320
Haslak, Fatih https://orcid.org/0000-0002-6963-9668
Adrovic, Amra https://orcid.org/0000-0002-2400-6955
Sahin, Sezgin https://orcid.org/0000-0002-5365-3457
Barut, Kenan https://orcid.org/0000-0001-8459-2872
Kasapcopur, Ozgur https://orcid.org/0000-0002-1125-7720
License Information

Text and Data Mining valid from 2023-06-06

Version of Record valid from 2023-06-06
More Information

Article History

Received: 27 April 2023

Accepted: 25 May 2023

First Online: 6 June 2023

Declarations

:

: None of the authors of this paper has a conflict of interest, including specific financial interests, relationships and/or affiliations with pharma promoting IL-1 antagonists.